☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
immunome
Immunome to Acquire Ayala Pharmaceuticals’ AL102 for the Treatment of Desmoid Tumors
February 7, 2024
Matthew Robinson, CTO, Immunome Shares Insights on Strategic Collaboration with AbbVie to Identify Multiple Novel Oncology Targets
May 9, 2023
PharmaShots Interview: Purnanand Sarma, CEO of Immunome, Shares Insights on R&D Update IL-38 Targeting Antibody Treatment for Canc...
August 2, 2022
Load more...
Back to Home
Modal title
×
Modal body text goes here.